4-112904455-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_ModerateBP6_ModerateBS1BS2
The NM_001386142.1(ANK2):c.-39G>C variant causes a splice region change. The variant allele was found at a frequency of 0.000753 in 1,429,550 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/2 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00085 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00074 ( 8 hom. )
Consequence
ANK2
NM_001386142.1 splice_region
NM_001386142.1 splice_region
Scores
2
Splicing: ADA: 0.7931
2
Clinical Significance
Conservation
PhyloP100: 5.71
Publications
1 publications found
Genes affected
ANK2 (HGNC:493): (ankyrin 2) This gene encodes a member of the ankyrin family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton. Ankyrins play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. The protein encoded by this gene is required for targeting and stability of Na/Ca exchanger 1 in cardiomyocytes. Mutations in this gene cause long QT syndrome 4 and cardiac arrhythmia syndrome. Multiple transcript variants encoding different isoforms have been described. [provided by RefSeq, Dec 2011]
ANK2 Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Ambry Genetics, ClinGen
- Brugada syndromeInheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Genomics England PanelApp, ClinGen
- catecholaminergic polymorphic ventricular tachycardiaInheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp
- heart conduction diseaseInheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
- neurodevelopmental disorderInheritance: AD Classification: LIMITED Submitted by: G2P
- cardiac arrhythmia, ankyrin-B-relatedInheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- long QT syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.21).
BP6
Variant 4-112904455-G-C is Benign according to our data. Variant chr4-112904455-G-C is described in ClinVar as [Benign]. Clinvar id is 2655031.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000848 (129/152050) while in subpopulation NFE AF = 0.000397 (27/67960). AF 95% confidence interval is 0.00028. There are 1 homozygotes in GnomAd4. There are 62 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 129 AD,Unknown gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANK2 | NM_001386142.1 | c.-39G>C | splice_region_variant | Exon 2 of 45 | NP_001373071.1 | |||
ANK2 | NM_001386143.1 | c.-39G>C | splice_region_variant | Exon 2 of 48 | NP_001373072.1 | |||
ANK2 | NM_001354239.2 | c.-39G>C | splice_region_variant | Exon 2 of 49 | NP_001341168.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANK2 | ENST00000506722.5 | c.-39G>C | splice_region_variant | Exon 2 of 47 | 1 | ENSP00000421067.1 | ||||
ANK2 | ENST00000506722.5 | c.-39G>C | 5_prime_UTR_variant | Exon 2 of 47 | 1 | ENSP00000421067.1 | ||||
ANK2 | ENST00000672209.1 | c.-39G>C | splice_region_variant | Exon 2 of 48 | ENSP00000499982.1 |
Frequencies
GnomAD3 genomes AF: 0.000849 AC: 129AN: 151934Hom.: 1 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
129
AN:
151934
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00193 AC: 255AN: 132364 AF XY: 0.00198 show subpopulations
GnomAD2 exomes
AF:
AC:
255
AN:
132364
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000741 AC: 947AN: 1277500Hom.: 8 Cov.: 20 AF XY: 0.000762 AC XY: 483AN XY: 633550 show subpopulations
GnomAD4 exome
AF:
AC:
947
AN:
1277500
Hom.:
Cov.:
20
AF XY:
AC XY:
483
AN XY:
633550
show subpopulations
African (AFR)
AF:
AC:
3
AN:
27914
American (AMR)
AF:
AC:
2
AN:
29332
Ashkenazi Jewish (ASJ)
AF:
AC:
623
AN:
23894
East Asian (EAS)
AF:
AC:
0
AN:
33940
South Asian (SAS)
AF:
AC:
11
AN:
68636
European-Finnish (FIN)
AF:
AC:
0
AN:
48734
Middle Eastern (MID)
AF:
AC:
17
AN:
5428
European-Non Finnish (NFE)
AF:
AC:
189
AN:
985988
Other (OTH)
AF:
AC:
102
AN:
53634
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
37
74
110
147
184
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.000848 AC: 129AN: 152050Hom.: 1 Cov.: 33 AF XY: 0.000834 AC XY: 62AN XY: 74320 show subpopulations
GnomAD4 genome
AF:
AC:
129
AN:
152050
Hom.:
Cov.:
33
AF XY:
AC XY:
62
AN XY:
74320
show subpopulations
African (AFR)
AF:
AC:
5
AN:
41490
American (AMR)
AF:
AC:
6
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
AC:
81
AN:
3466
East Asian (EAS)
AF:
AC:
0
AN:
5186
South Asian (SAS)
AF:
AC:
1
AN:
4816
European-Finnish (FIN)
AF:
AC:
0
AN:
10564
Middle Eastern (MID)
AF:
AC:
4
AN:
292
European-Non Finnish (NFE)
AF:
AC:
27
AN:
67960
Other (OTH)
AF:
AC:
5
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3448
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
ANK2: BS1, BS2 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.